NASDAQ · LUCD
Lucid Diagnostics Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for LUCD: Nov 12, 2026
Lucid Diagnostics Inc. Common Stock is expected to report earnings on 11/12/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.05. The reported EPS for the same quarter last year was $-0.11.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Dec 2026 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Mar 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Jun 2027 | $-0.05 | $-0.05 | $-0.05 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · The Motley Fool · MarketBeat- RTTNews · Oct 23, 3:00 PM EDTBiotech Stocks On Investor Radar – BOLT +66%, LYCA +33%, LUCD, GMAB(RTTNews) – Shares of several biotech companies moved higher following corporate, financing and clinical developments. Bolt Biotherapeutics gained after announcing a reverse merger with Prana Therapies and a $120 million private placement, Lycia Therapeutics surged in its Nasdaq
- RTTNews · Oct 22, 11:14 PM EDTLucid Shares Jump 40% Overnight On EsoGuard Medicare Payments, $15 Mln Financing(RTTNews) – Shares of Lucid Diagnostics Inc. (LUCD) rose about 40% in overnight trading after the PAVmed subsidiary on Thursday said it had begun receiving Medicare payments for its EsoGuard Esophageal DNA Test and closed a $15 million private placement.
- Fintel · Oct 22, 9:38 PM EDTLucid Diagnostics Inc. Closes $15.0 million Series C Preferred Stock OfferingLucid Diagnostics Inc. entered into subscription agreements on October 21, 2026, with certain accredited investors for the sale of 15,000 shares of newly designated Series C Convertible Preferred Stock. The shares were sold at a purchase price of $1,000 per share, yielding aggreg
- The Motley Fool · Oct 1, 5:20 AM EDT3 Key Reasons to Buy This Huge Turnaround Story That's Gaining TractionDeveloping new global partnerships, where former leadership preferred an insular approach, is a great shift.
- The Motley Fool · Aug 20, 9:58 AM EDTLucid Diagnostics (LUCD) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 15, 1:01 AM EDTLucid Diagnostics Eyes Medicare Catalyst for EsoGuard GrowthOctober's 4 Best Penny Stocks: High-Risk, High-Reward PicksLucid Diagnostics (NASDAQ:LUCD) is positioning its EsoGuard test as a non-invasive tool to identify Barrett’s Esophagus, a precancerous condition associated with esophageal cancer, while it awaits a key Medicare coverage
- MarketBeat · Aug 13, 2:04 PM EDTLucid Diagnostics Q2 Earnings Call HighlightsOctober's 4 Best Penny Stocks: High-Risk, High-Reward PicksLucid Diagnostics (NASDAQ:LUCD) reported second-quarter revenue of $1.5 million on 2,770 EsoGuard tests, as the company continued to target quarterly test volume of roughly 2,500 to 3,000 tests while awaiting a Medicare d
- Zacks · Aug 13, 9:10 AM EDTLucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue EstimatesLucid Diagnostics (LUCD) delivered earnings and revenue surprises of -50.00% and -1.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 11, 9:00 AM EDTNeuronetics (STIM) Reports Q2 Loss, Beats Revenue EstimatesNeuronetics (STIM) delivered earnings and revenue surprises of +54.55% and +3.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 6, 7:10 PM EDTPulse Biosciences, Inc (PLSE) Reports Q2 Loss, Misses Revenue EstimatesPulse Biosciences (PLSE) delivered earnings and revenue surprises of -16.13% and -38.00%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 7:27 AM EDTFocalTherics (FOCL) Surges 6.2%: Is This an Indication of Further Gains?FocalTherics (FOCL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- Zacks · Aug 4, 7:00 PM EDTAlphatec (ATEC) Q2 Earnings Lag EstimatesAlphatec (ATEC) delivered earnings and revenue surprises of -22.22% and +1.04%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Lucid Diagnostics Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.